RTW vs. MRC, BHMG, MYI, WWH, ATT, N91, VEIL, FEV, PNL, and JTC
Should you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include The Mercantile Investment Trust (MRC), BH Macro GBP (BHMG), Murray International (MYI), Worldwide Healthcare (WWH), Allianz Technology Trust (ATT), Ninety One Group (N91), Vietnam Enterprise (VEIL), Fidelity European Trust (FEV), Personal Assets (PNL), and JTC (JTC). These companies are all part of the "asset management" industry.
RTW Biotech Opportunities vs. Its Competitors
The Mercantile Investment Trust (LON:MRC) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.
The Mercantile Investment Trust has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500.
RTW Biotech Opportunities has lower revenue, but higher earnings than The Mercantile Investment Trust. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than The Mercantile Investment Trust, indicating that it is currently the more affordable of the two stocks.
RTW Biotech Opportunities has a net margin of 664.38% compared to The Mercantile Investment Trust's net margin of 94.67%. RTW Biotech Opportunities' return on equity of 25.18% beat The Mercantile Investment Trust's return on equity.
13.0% of The Mercantile Investment Trust shares are held by institutional investors. Comparatively, 6.8% of RTW Biotech Opportunities shares are held by institutional investors. 0.1% of The Mercantile Investment Trust shares are held by company insiders. Comparatively, 0.6% of RTW Biotech Opportunities shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, The Mercantile Investment Trust had 1 more articles in the media than RTW Biotech Opportunities. MarketBeat recorded 1 mentions for The Mercantile Investment Trust and 0 mentions for RTW Biotech Opportunities. The Mercantile Investment Trust's average media sentiment score of 1.76 beat RTW Biotech Opportunities' score of 1.35 indicating that The Mercantile Investment Trust is being referred to more favorably in the media.
Summary
The Mercantile Investment Trust beats RTW Biotech Opportunities on 9 of the 13 factors compared between the two stocks.
Get RTW Biotech Opportunities News Delivered to You Automatically
Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
RTW Biotech Opportunities Competitors List
Related Companies and Tools
This page (LON:RTW) was last updated on 8/31/2025 by MarketBeat.com Staff
Free RTW Stock Alerts